Alcon Gets Rare Sell Rating as BofA Flags Earnings Growth Risk

Alcon Inc., the Swiss eye-care specialist, got its first bearish mark from analysts since August after Bank of America Corp. double downgraded the stock, warning that a slower rollout of its new eye-surgery machines will pressure profit growth.